METHOD FOR PREVENTION OF TUBERCULOUS PROCESS REACTIVATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE OF FIFTH STAGE UNDERGOING PROGRAM HAEMODIALYSIS
2023-12-19
专利权人CENT RES INST TUBERCULOSIS (RETU-Non-standard)
申请日期2023-12-19
专利号RU2835986-C1
成果简介NOVELTY - Invention refers to medicine, namely to phthisiology, and can be used for prevention of tuberculosis process reactivation in patients with chronic kidney disease undergoing programmed haemodialysis. Previously, the history of tuberculosis is studied and the patients are divided into groups of patients, including the first group of patients with the presence of contraindications to the use of isoniazid, in the second group of patients with the presence of contraindications to the use of rifampicin, in the third group of patients with the presence of contraindications to the use of isoniazid and rifampicin. For the first group of patients, the duration of chemoprophylaxis (CP) is 2 months of taking a two-component combination: rifampicin in dose of 50% of the therapeutic dose calculated according to the patient's weight, and ethambutol in dose of 5–7.5 mg/kg/day. For the second group of patients, CP is 2 months of taking a two-component combination: isoniazid in dose of 200–300 mg/day and ethambutol in dose of 5–7.5 mg/kg/day. For the third group of patients, CP is 2 months of a two-component combination: ethambutol in dose of 5–7.5 mg/kg/day and moxifloxacin 400 mg/day. Above anti-tuberculosis preparations are taken daily. USE - Medicine. ADVANTAGE - Method enables avoiding tuberculous process reactivation with underlying programmed haemodialysis by using said chemoprophylaxis regimens. 2 cl, 6 dwg, 3 ex
IPC 分类号A61K-031/195 ; A61K-031/4409 ; A61K-031/496 ; A61P-031/06
国家俄罗斯
专业领域化学化工
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/18862
专题中国科学院新疆生态与地理研究所
作者单位
CENT RES INST TUBERCULOSIS (RETU-Non-standard)
推荐引用方式
GB/T 7714
GORDEEVA O M,TIKHONOV A M,BORISOVA A I,et al. METHOD FOR PREVENTION OF TUBERCULOUS PROCESS REACTIVATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE OF FIFTH STAGE UNDERGOING PROGRAM HAEMODIALYSIS. RU2835986-C1[P]. 2023.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。